Rutgers, The State University of New Jersey;Reva Medical, Inc.
发明人:
Durgadas Bolikal,Joachim B. Kohn,Lioubov Kabalnova
申请号：
US16439232
公开号：
US20190292312A1
申请日:
2019.06.12
申请国别(地区):
US
年份:
2019
代理人:
摘要：
The present invention provides new classes of phenolic compounds derived from hydroxyacids and tyrosol or tyrosol analogues, useful as monomers for preparation of biocompatible polymers, and the biocompatible polymers prepared from these monomeric hydroxyacid-phenolic compounds, including novel biodegradable and/or bioresorbable polymers. These biocompatible polymers or polymer compositions with enhanced bioresorbabilty and processability are useful in a variety of medical applications, such as in medical devices and controlled-release therapeutic formulations. The invention also provides methods for preparing these monomeric hydroxyacid-phenolic compounds and biocompatible polymers.
